European Hematology Association - 31st Congress, 2026 (EHA) 11 - 14 June 2026

Phase 1/2 hibiscus kids study of etavopivat in pediatric patients with sickle cell disease: safety and efficacy findings from the complete first cohort

Authors :

Bernhards Ogutu^{1, 2}; Miguel R. Abboud³; Subarna Chakravorty⁴; Iheanyi Okpala⁵; Pavithra Dhayakar⁶; Leila

Jerome Clay⁷; Kaming Lo ⁸; Adlette Inati^{9, 10}

Affiliations

View Details Hide Details

Download poster (.pdf)

Keywords

Sickle Cell Disease

Congress oral presentation

Etavopivat

Are you a healthcare professional?